We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$966M
AUM Growth
+$91.6M
Cap. Flow
+$43M
Cap. Flow %
4.45%
Top 10 Hldgs %
39.47%
Holding
978
New
62
Increased
301
Reduced
181
Closed
434

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$9.33M
2
GEN icon
Gen Digital
GEN
+$7.29M
3
CHKP icon
Check Point Software Technologies
CHKP
+$7.15M
4
PANW icon
Palo Alto Networks
PANW
+$7.07M
5
CSCO icon
Cisco
CSCO
+$6.33M

Sector Composition

Rank Sector Weight
1 Technology 84.87%
2 Industrials 4.61%
3 Consumer Discretionary 2.8%
4 Communication Services 1.97%
5 Financials 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
251
Zimmer Biomet
ZBH
$18.2B
$157K 0.02%
1,327
+116
+10% +$13.1K
COO icon
252
Cooper Companies
COO
$14.1B
$156K 0.02%
3,128
+272
+10% +$12.9K
SSYS icon
253
Stratasys
SSYS
$679M
$153K 0.02%
7,476
+3,204
+75% +$63.4K
AGNC icon
254
AGNC Investment
AGNC
$12.4B
$152K 0.02%
7,649
+2,261
+42% +$43.6K
CSGP icon
255
CoStar Group
CSGP
$11.7B
$152K 0.02%
7,360
+640
+10% +$13K
RTX icon
256
RTX Corp
RTX
$290B
$151K 0.02%
2,145
-1,306
-38% -$91.6K
NICE icon
257
Nice
NICE
$5.79B
$150K 0.02%
2,208
-820
-27% -$56.3K
GLPI icon
258
Gaming and Leisure Properties
GLPI
$12.7B
$149K 0.02%
4,474
+2,228
+99% +$70.3K
INGR icon
259
Ingredion
INGR
$6.27B
$149K 0.02%
1,242
+108
+10% +$13.2K
EL icon
260
Estee Lauder
EL
$30.4B
$148K 0.02%
1,748
-61
-3% -$5.04K
INTC icon
261
Intel
INTC
$455B
$146K 0.02%
4,048
-6,783
-63% -$245K
VAR
262
DELISTED
Varian Medical Systems, Inc.
VAR
$146K 0.02%
1,610
-66
-4% -$5.5K
GAP
263
The Gap Inc
GAP
$7.23B
$145K 0.02%
5,980
+520
+10% +$12.4K
MON
264
DELISTED
Monsanto Co
MON
$145K 0.02%
1,288
+112
+10% +$12.4K
AMGN icon
265
Amgen
AMGN
$208B
$143K 0.01%
874
+76
+10% +$12.6K
APO icon
266
Apollo Global Management
APO
$72.4B
$143K 0.01%
5,890
+2,918
+98% +$65.1K
MJN
267
DELISTED
Mead Johnson Nutrition Company
MJN
$143K 0.01%
1,610
-139
-8% -$11.4K
ABBV icon
268
AbbVie
ABBV
$443B
$140K 0.01%
2,162
+188
+10% +$11.8K
EW icon
269
Edwards Lifesciences
EW
$49.6B
$138K 0.01%
4,416
-285
-6% -$8.92K
PVH icon
270
PVH
PVH
$4B
$138K 0.01%
1,334
+116
+10% +$10.7K
PNR icon
271
Pentair
PNR
$10.4B
$135K 0.01%
3,219
-285
-8% -$11.4K
ILMN icon
272
Illumina
ILMN
$31B
$133K 0.01%
804
-55
-6% -$8.67K
ALXN
273
DELISTED
Alexion Pharmaceuticals
ALXN
$133K 0.01%
1,104
-37
-3% -$4.77K
CMPR icon
274
Cimpress
CMPR
$2.39B
$132K 0.01%
1,536
+667
+77% +$57.7K
STWD icon
275
Starwood Property Trust
STWD
$5.92B
$132K 0.01%
5,867
+2,015
+52% +$45.5K

Similar funds

Penserra Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Penserra Capital Management held 978 positions worth $966M, up 10% from $875M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Penserra Capital Management deployed $43M of net new capital in Q1 2017, opening 62 new positions and adding to 301 existing holdings. Its largest new stake was Akamai: 582,110 shares worth $34.8M.

By sector, the portfolio is most concentrated in Technology at 85% of assets, up from 82% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fortinet, an estimated $9.33M trimmed.

  • Penserra Capital Management's largest Q1 2017 buy was Akamai: 582,110 shares worth $34.8M.
  • Penserra Capital Management added most to Varonis Systems in Q1 2017, an estimated $15.9M increase.
  • Penserra Capital Management's biggest Q1 2017 reduction was Fortinet, cutting an estimated $9.33M.
  • Penserra Capital Management fully exited Mastercard in Q1 2017, selling an estimated $2.91M.
  • Penserra Capital Management's ten largest holdings make up 39% of its $966M portfolio in Q1 2017.
  • Penserra Capital Management opened 62 new positions and closed 434 in Q1 2017.
  • Penserra Capital Management's portfolio value rose 10% quarter-over-quarter to $966M.

Based on Penserra Capital Management's 13F filing for Q1 2017, filed 9 May 2017.